SFDA to penalize 996 erring establishments
RIYADH — Inspection teams from the Saudi Food and Drug Authority (SFDA) have detected violations of 996 establishments during inspection teams carried out during the last two months of April and May. The authority officials conducted 5,912 monitoring and investigation tours, resulting in the seizure of 996 violating establishments out of 4,307 establishments that covered inspections in various regions across the Kingdom.
The inspection tours also resulted in the closure of 136 establishments for not obtaining the necessary licenses and for violations affecting product safety. In addition, 127 production lines were suspended and 1,750 types of products were seized and impounded. This comes as part of the authority's efforts to verify the compliance of establishments subject to its supervision with approved regulations and to achieve the highest levels of quality for products circulating in the markets.
During these tours, the authority's inspection teams were able to seize violations of a food establishment where raw materials of unknown origin were found. It was also found that a number of workers were employed without health certificates that necessitated the closure of the facility by the authority and the adoption of necessary punitive measures.
Several unlicensed warehouses were seized for illegally storing expired medical products, in conditions that violated transportation and storage requirements for medical products. A total of 313,789 products were immediately seized, and regulatory measures were completed against the violators to ensure consumer protection from unsafe products.
The authority officials also seized a food factory that had committed several violations, including failure to obtain a Hazard Analysis Critical Control Points (HACCP) quality certificate, the accumulation of meat in raw material freezers, and signs of spoilage on some aged meat. In addition, the external production date did not match the production date on the product, and there was a noticeable decline in hygiene within the facility. Furthermore, some workers did not have health certificates. The inspection teams seized 2,000 kilograms of food products unfit for consumption. The authority is completing regulatory measures against the factory.
During joint inspection tours, carried out along with the Saudi Authority for Industrial Cities and Technology Zones (MODON), the SFDA teams detected a number of violations on the part of a factory under construction. The most notable violations included the lack of a license from the SFDA, a complete lack of food safety regulations, manufacturing practices and production lines that violate food production requirements, and several violations affecting safety and quality. This prompted the closure of the factory and production lines, the precautionary recall of products pending analysis results to ensure their safety, and the adoption of legal action against the erring factory.
The authority emphasized the need for facilities subject to its supervision to adhere to approved regulations and systems. It called for reporting any violations through contacting the unified number 19999.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Saudi Gazette
2 days ago
- Saudi Gazette
SFDA approves 'Winrevair' for rare pulmonary hypertension treatment
Saudi Gazette report RIYADH — The Saudi Food and Drug Authority (SFDA) has approved the registration of Winrevair (sotatercept) for the treatment of adult patients with World Health Organization (WHO) Functional Class II to III pulmonary arterial hypertension (PAH). Previously designated as an orphan drug under SFDA's Orphan Drugs Program, Winrevair addresses a critical need for patients with this life-threatening condition. PAH is characterized by the narrowing and thickening of blood vessels in the lungs, leading to symptoms such as shortness of breath, chest pain, and fatigue. Winrevair introduces a novel mechanism of action by inhibiting activin signaling, which plays a role in the thickening of pulmonary arteries. By restoring cellular growth balance, the drug improves blood flow in the lungs, reduces strain on the heart, and enhances oxygen delivery and physical endurance, thereby improving patients' quality of life. The SFDA confirmed that the drug's approval followed a comprehensive evaluation of its efficacy, safety, and quality, meeting all regulatory requirements. Clinical trials demonstrated a statistically significant and clinically meaningful reduction in the risk of disease progression or death in WHO Class II–III patients. The most common side effects reported were headache, nosebleeds, and skin itching, which were generally mild and manageable. The SFDA reiterated its commitment to supporting access to effective treatments, especially in the rare and difficult-to-treat disease space, which often suffers from limited therapeutic options. The authority's Orphan Drugs Program plays a strategic role in advancing pharmaceutical innovation and addressing unmet medical needs. Under the program, orphan drugs are defined as those intended to treat diseases affecting fewer than five individuals per 10,000 people in Saudi Arabia. The program offers benefits to pharmaceutical companies, including pre-submission meetings, priority review, and scientific consultations.
Saudi Gazette
3 days ago
- Saudi Gazette
Saudi Arabia adopts World Drowning Prevention Day as national health priority
Saudi Gazette report RIYADH — Saudi Arabia has officially adopted World Drowning Prevention Day, marking July 25 of each year as a national observance dedicated to raising awareness and enhancing water safety, following a Cabinet session chaired by Crown Prince Mohammed bin Salman in Jeddah on Tuesday. Minister of Health Fahad Al-Jalajel said the decision reflects the Kingdom's firm commitment to safeguarding public health and preventing avoidable injuries and deaths. He added that it aligns with the goals of the Health Sector Transformation Program, part of Saudi Vision 2030, which aims to build a vibrant society and ensure the well-being of all residents. Al-Jalajel praised the efforts of national health and safety agencies in formulating and implementing the National Drowning Prevention Policy, which has helped reduce drowning-related fatalities by more than 17% per 100,000 people. This, he noted, has saved the Saudi economy approximately SR800 million, according to validated local and international reports. The minister emphasized that Saudi Arabia's adoption of this day is part of its broader 'Health in All Policies' approach. He said it reflects the Kingdom's global leadership in water safety, noting that the World Health Organization ranked Saudi Arabia first in 2024 among 140 countries for meeting the highest standards in water safety and rescue protocols. Al-Jalajel added that the health system will continue to implement preventive awareness campaigns and rapid response programs, while expanding collaboration with relevant sectors to ensure the highest standards of water safety whether in homes, recreational facilities, tourist destinations, or public beaches and swimming pools. He concluded by affirming that the ministry, in partnership with stakeholders, remains committed to promoting community awareness, developing preventive policies, and creating a safer, healthier environment for all.
Saudi Gazette
03-07-2025
- Saudi Gazette
SFDA to penalize 996 erring establishments
Saudi Gazette report RIYADH — Inspection teams from the Saudi Food and Drug Authority (SFDA) have detected violations of 996 establishments during inspection teams carried out during the last two months of April and May. The authority officials conducted 5,912 monitoring and investigation tours, resulting in the seizure of 996 violating establishments out of 4,307 establishments that covered inspections in various regions across the Kingdom. The inspection tours also resulted in the closure of 136 establishments for not obtaining the necessary licenses and for violations affecting product safety. In addition, 127 production lines were suspended and 1,750 types of products were seized and impounded. This comes as part of the authority's efforts to verify the compliance of establishments subject to its supervision with approved regulations and to achieve the highest levels of quality for products circulating in the markets. During these tours, the authority's inspection teams were able to seize violations of a food establishment where raw materials of unknown origin were found. It was also found that a number of workers were employed without health certificates that necessitated the closure of the facility by the authority and the adoption of necessary punitive measures. Several unlicensed warehouses were seized for illegally storing expired medical products, in conditions that violated transportation and storage requirements for medical products. A total of 313,789 products were immediately seized, and regulatory measures were completed against the violators to ensure consumer protection from unsafe products. The authority officials also seized a food factory that had committed several violations, including failure to obtain a Hazard Analysis Critical Control Points (HACCP) quality certificate, the accumulation of meat in raw material freezers, and signs of spoilage on some aged meat. In addition, the external production date did not match the production date on the product, and there was a noticeable decline in hygiene within the facility. Furthermore, some workers did not have health certificates. The inspection teams seized 2,000 kilograms of food products unfit for consumption. The authority is completing regulatory measures against the factory. During joint inspection tours, carried out along with the Saudi Authority for Industrial Cities and Technology Zones (MODON), the SFDA teams detected a number of violations on the part of a factory under construction. The most notable violations included the lack of a license from the SFDA, a complete lack of food safety regulations, manufacturing practices and production lines that violate food production requirements, and several violations affecting safety and quality. This prompted the closure of the factory and production lines, the precautionary recall of products pending analysis results to ensure their safety, and the adoption of legal action against the erring factory. The authority emphasized the need for facilities subject to its supervision to adhere to approved regulations and systems. It called for reporting any violations through contacting the unified number 19999.
